Ruchita Sinha is a Senior Partner at ARTIS Ventures.

Ruchita is interested in the convergence of biology, healthcare, data, and AI. In an investing career spanning more than a decade, she has been involved with over 30 life science and healthcare startups including 5 IPOs, 6 acquisitions, and multiple unicorns. Most recently, as a General Partner at AV8 Ventures, Ruchita helped drive the firm’s healthcare investment strategy and partnered with entrepreneurs to help build successful companies. She is an investor and/or board member in Phenomic AI, Think Bio, Shennon Bio, ALLIn Bio, SimBioSys, Clever Care, Axuall, Yuvo Health, CuraFi, and
Flourish Health. She is also on the advisory board of the BIO Investor Forum.

Before AV8, Ruchita was an investor at Sanofi Ventures and GE Ventures, where she was named to the Global Corporate Venturing Powerlist in 2018 and 2019. She began her career as a scientist at Maxygen and then was in business roles at Pfizer and LEK Consulting.
 

Ruchita holds an MBA from the University of Chicago Booth School of Business, an MS in Cellular and Molecular Biology from the University of Wisconsin-Madison, and a BS in Biochemistry from Mount Holyoke College.